Cost benefits

Improving patient compliance, even slightly, can significantly increase your revenues, as well as reducing expenses for your customers and patients. The WHO and Verispan, have suggested that for a $1 billion product, a 5% increase in patient adherence could deliver a further $30 – 40 million of revenue.

Partnering with Healthcare at Home also means you can offer your customers a better service at lower cost:

• Efficient use of high-value medication through regular patient education and monitoring of compliance, concordance, symptoms and patient stock-holding
• A recent study showed that Healthcare at Home treatment for a wide range of conditions was approximately 80% less expensive than comparable in-hospital treatment
• Independent analysis of our services, concluded more widespread adoption within the NHS could potentially reduce costs by over £1 billion per annum.
• Reducing capacity pressure within the hospital reduces future investment requirements and/or enables greater focus on more specialist services and reduced waiting times
• Working capital is released through reduced hospital requirement for holding stock of high value drugs